Skip to main content
Top
Published in: Clinical and Experimental Medicine 7/2023

18-06-2023 | Acute Respiratory Distress-Syndrome | Review

Interesting effects of interleukins and immune cells on acute respiratory distress syndrome

Authors: Najmaldin Saki, Mohammadreza Javan, Bahareh Moghimian-Boroujeni, Richard Eric Kast

Published in: Clinical and Experimental Medicine | Issue 7/2023

Login to get access

Abstract

Acute respiratory distress syndrome (ARDS) is a medical condition characterized by widespread inflammation in the lungs with consequent proportional loss of gas exchange function. ARDS is linked with severe pulmonary or systemic infection. Several factors, including secretory cytokines, immune cells, and lung epithelial and endothelial cells, play a role in the development and progression of this disease. The present study is based on Pubmed database information (1987–2022) using the words "Acute respiratory distress syndrome", "Interleukin", "Cytokines" and "Immune cells". Cytokines and immune cells play an important role in this disease, with particular emphasis on the balance between pro-inflammatory and anti-inflammatory factors. Neutrophils are one of several important mediators of Inflammation, lung tissue destruction, and malfunction during ARDS. Some immune cells, such as macrophages and eosinophils, play a dual role in releasing inflammatory mediators, recruitment inflammatory cells and the progression of ARDS, or releasing anti-inflammatory mediators, clearing the lung of inflammatory cells, and helping to improve the disease. Different interleukins play a role in the development or inhibition of ARDS by helping to activate various signaling pathways, helping to secrete other inflammatory or anti-inflammatory interleukins, and playing a role in the production and balance between immune cells involved in ARDS. As a result, immune cells and, inflammatory cytokines, especially interleukins play an important role in the pathogenesis of this disease Therefore, understanding the relevant mechanisms will help in the proper diagnosis and treatment of this disease.
Literature
2.
go back to reference McNicholas BA, Rooney GM, Laffey JG. Lessons to learn from epidemiologic studies in ARDS. Curr Opin Crit Care. 2018;24(1):41–8.CrossRefPubMed McNicholas BA, Rooney GM, Laffey JG. Lessons to learn from epidemiologic studies in ARDS. Curr Opin Crit Care. 2018;24(1):41–8.CrossRefPubMed
42.
go back to reference Hui L, Zhang X, An X, et al. Higher serum procalcitonin and IL-6 levels predict worse diagnosis for acute respiratory distress syndrome patients with multiple organ dysfunction. Int J Clin Exp Pathol. 2017;10(7):7401–7.PubMedPubMedCentral Hui L, Zhang X, An X, et al. Higher serum procalcitonin and IL-6 levels predict worse diagnosis for acute respiratory distress syndrome patients with multiple organ dysfunction. Int J Clin Exp Pathol. 2017;10(7):7401–7.PubMedPubMedCentral
48.
go back to reference Rambaldi A, Young DC, Griffin JD (1987) Expression of the M-CSF (CSF-1) gene by human monocytes Rambaldi A, Young DC, Griffin JD (1987) Expression of the M-CSF (CSF-1) gene by human monocytes
49.
go back to reference Seelentag W, Mermod J, Montesano R, Vassalli P. Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J. 1987;6(8):2261–5.CrossRefPubMedPubMedCentral Seelentag W, Mermod J, Montesano R, Vassalli P. Additive effects of interleukin 1 and tumour necrosis factor-alpha on the accumulation of the three granulocyte and macrophage colony-stimulating factor mRNAs in human endothelial cells. EMBO J. 1987;6(8):2261–5.CrossRefPubMedPubMedCentral
55.
go back to reference Kanoh S, Tanabe T, Rubin BK. Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret. Chest. 2011;140(4):980–90.CrossRefPubMed Kanoh S, Tanabe T, Rubin BK. Dapsone inhibits IL-8 secretion from human bronchial epithelial cells stimulated with lipopolysaccharide and resolves airway inflammation in the ferret. Chest. 2011;140(4):980–90.CrossRefPubMed
56.
go back to reference Schmidt E, Reimer S, Kruse N, Bröcker EB, Zillikens D. The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol. 2001;124(1):157–62.CrossRefPubMedPubMedCentral Schmidt E, Reimer S, Kruse N, Bröcker EB, Zillikens D. The IL-8 release from cultured human keratinocytes, mediated by antibodies to bullous pemphigoid autoantigen 180, is inhibited by dapsone. Clin Exp Immunol. 2001;124(1):157–62.CrossRefPubMedPubMedCentral
62.
go back to reference Roh JS, Sohn DH (2018) Damage-associated molecular patterns in inflammatory diseases. Immune network 18(4) Roh JS, Sohn DH (2018) Damage-associated molecular patterns in inflammatory diseases. Immune network 18(4)
68.
71.
go back to reference Bekenova N, Grjibovski A, Mukovozova L, Smail E, Tokaeva A. Rs8193036 polymorphism of IL-17A gene in a Kazakh population and its association with plasma IL-17A among erysipelas patients. Ekologiya Cheloveka (Human Ecology). 2016;4:50–5.CrossRef Bekenova N, Grjibovski A, Mukovozova L, Smail E, Tokaeva A. Rs8193036 polymorphism of IL-17A gene in a Kazakh population and its association with plasma IL-17A among erysipelas patients. Ekologiya Cheloveka (Human Ecology). 2016;4:50–5.CrossRef
83.
go back to reference Cao J, Xu F, Lin S, et al. IL-35 is elevated in clinical and experimental sepsis and mediates inflammation. Clin Immunol. 2015;161(2):89–95.CrossRefPubMed Cao J, Xu F, Lin S, et al. IL-35 is elevated in clinical and experimental sepsis and mediates inflammation. Clin Immunol. 2015;161(2):89–95.CrossRefPubMed
92.
93.
go back to reference Thapa K, Verma N, Singh TG, Grewal AK, Kanojia N, Rani L. COVID-19-Associated acute respiratory distress syndrome (CARDS): mechanistic insights on therapeutic intervention and emerging trends. Int Immunopharmacol. 2021;101: 108328.CrossRefPubMedPubMedCentral Thapa K, Verma N, Singh TG, Grewal AK, Kanojia N, Rani L. COVID-19-Associated acute respiratory distress syndrome (CARDS): mechanistic insights on therapeutic intervention and emerging trends. Int Immunopharmacol. 2021;101: 108328.CrossRefPubMedPubMedCentral
94.
go back to reference Middleton EA, Zimmerman GA. COVID-19–associated acute respiratory distress syndrome: lessons from tissues and cells. Crit Care Clin. 2021;37(4):777–93.CrossRefPubMedCentral Middleton EA, Zimmerman GA. COVID-19–associated acute respiratory distress syndrome: lessons from tissues and cells. Crit Care Clin. 2021;37(4):777–93.CrossRefPubMedCentral
95.
go back to reference Ramadori GP. SARS-CoV-2-infection (COVID-19): clinical course, viral acute respiratory distress syndrome (ARDS) and cause (s) of death. Medi Sci. 2022;10(4):58. Ramadori GP. SARS-CoV-2-infection (COVID-19): clinical course, viral acute respiratory distress syndrome (ARDS) and cause (s) of death. Medi Sci. 2022;10(4):58.
96.
go back to reference Franzetti M, Forastieri A, Borsa N, et al. IL-1 receptor antagonist anakinra in the treatment of COVID-19 acute respiratory distress syndrome: a retrospective, observational study. J Immunol. 2021;206(7):1569–75.CrossRefPubMedPubMedCentral Franzetti M, Forastieri A, Borsa N, et al. IL-1 receptor antagonist anakinra in the treatment of COVID-19 acute respiratory distress syndrome: a retrospective, observational study. J Immunol. 2021;206(7):1569–75.CrossRefPubMedPubMedCentral
97.
go back to reference Alladina JW, Levy SD, Hibbert KA, et al. Plasma concentrations of soluble ST2 and IL-6 are predictive of successful liberation from mechanical ventilation in patients with the acute respiratory distress syndrome. Crit Care Med. 2016;44(9):1735.CrossRefPubMedPubMedCentral Alladina JW, Levy SD, Hibbert KA, et al. Plasma concentrations of soluble ST2 and IL-6 are predictive of successful liberation from mechanical ventilation in patients with the acute respiratory distress syndrome. Crit Care Med. 2016;44(9):1735.CrossRefPubMedPubMedCentral
99.
go back to reference Lang S, Li L, Wang X, et al. CXCL10/IP-10 neutralization can ameliorate lipopolysaccharide-induced acute respiratory distress syndrome in rats. PLoS ONE. 2017;12(1): e0169100.CrossRefPubMedPubMedCentral Lang S, Li L, Wang X, et al. CXCL10/IP-10 neutralization can ameliorate lipopolysaccharide-induced acute respiratory distress syndrome in rats. PLoS ONE. 2017;12(1): e0169100.CrossRefPubMedPubMedCentral
100.
go back to reference Adamzik M, Broll J, Steinmann J, et al. An increased alveolar CD4+ CD25+ Foxp3+ T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality. Intens Care Med. 2013;39:1743–51.CrossRef Adamzik M, Broll J, Steinmann J, et al. An increased alveolar CD4+ CD25+ Foxp3+ T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality. Intens Care Med. 2013;39:1743–51.CrossRef
101.
go back to reference Peng J, Tang R, Qi D, et al. (2022) Predictive value of the baseline and early changes in blood eosinophils for short-term mortality in patients with acute respiratory distress syndrome. J Inflamm Res 1845–58 Peng J, Tang R, Qi D, et al. (2022) Predictive value of the baseline and early changes in blood eosinophils for short-term mortality in patients with acute respiratory distress syndrome. J Inflamm Res 1845–58
Metadata
Title
Interesting effects of interleukins and immune cells on acute respiratory distress syndrome
Authors
Najmaldin Saki
Mohammadreza Javan
Bahareh Moghimian-Boroujeni
Richard Eric Kast
Publication date
18-06-2023
Publisher
Springer International Publishing
Published in
Clinical and Experimental Medicine / Issue 7/2023
Print ISSN: 1591-8890
Electronic ISSN: 1591-9528
DOI
https://doi.org/10.1007/s10238-023-01118-w

Other articles of this Issue 7/2023

Clinical and Experimental Medicine 7/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Webinar | 06-02-2024 | 20:00 (CET)

Mastering chronic pancreatitis pain: A multidisciplinary approach and practical solutions

Severe pain is the most common symptom of chronic pancreatitis. In this webinar, experts share the latest insights in pain management for chronic pancreatitis patients. Experts from a range of disciplines discuss pertinent cases and provide practical suggestions for use within clinical practice.

Sponsored by: Viatris

Developed by: Springer Healthcare